These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 32779523)

  • 21. The Microbiome as a Component of the Tumor Microenvironment.
    Kovács T; Mikó E; Ujlaki G; Sári Z; Bai P
    Adv Exp Med Biol; 2020; 1225():137-153. PubMed ID: 32030653
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The gut microbiome-bile acid axis in hepatocarcinogenesis.
    Wu L; Feng J; Li J; Yu Q; Ji J; Wu J; Dai W; Guo C
    Biomed Pharmacother; 2021 Jan; 133():111036. PubMed ID: 33378947
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interaction of gut microbiota with dysregulation of bile acids in the pathogenesis of nonalcoholic fatty liver disease and potential therapeutic implications of probiotics.
    Chen J; Thomsen M; Vitetta L
    J Cell Biochem; 2019 Mar; 120(3):2713-2720. PubMed ID: 30443932
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gut Immunity and Microbiota Dysbiosis Are Associated with Altered Bile Acid Metabolism in LPS-Challenged Piglets.
    Xiao X; Cheng Y; Fu J; Lu Z; Wang F; Jin M; Zong X; Wang Y
    Oxid Med Cell Longev; 2021; 2021():6634821. PubMed ID: 33833852
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oncobiome at the Forefront of a Novel Molecular Mechanism to Understand the Microbiome and Cancer.
    Astudillo-de la Vega H; Alonso-Luna O; Ali-Pérez J; López-Camarillo C; Ruiz-Garcia E
    Adv Exp Med Biol; 2019; 1168():147-156. PubMed ID: 31713170
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bacterial Metabolites: A Link between Gut Microbiota and Dermatological Diseases.
    Stec A; Sikora M; Maciejewska M; Paralusz-Stec K; Michalska M; Sikorska E; Rudnicka L
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834904
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.
    Stecher B
    Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185088
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Microbiome analysis, the immune response and transplantation in the era of next generation sequencing.
    Kanangat S; Skaljic I
    Hum Immunol; 2021 Nov; 82(11):883-901. PubMed ID: 34364710
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bile Acids Activated Receptors in Inflammatory Bowel Disease.
    Biagioli M; Marchianò S; Carino A; Di Giorgio C; Santucci L; Distrutti E; Fiorucci S
    Cells; 2021 May; 10(6):. PubMed ID: 34064187
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Breast Cancer and Its Relationship with the Microbiota.
    Fernández MF; Reina-Pérez I; Astorga JM; Rodríguez-Carrillo A; Plaza-Díaz J; Fontana L
    Int J Environ Res Public Health; 2018 Aug; 15(8):. PubMed ID: 30110974
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulation of gut microbiota-bile acids axis by probiotics in inflammatory bowel disease.
    Li L; Liu T; Gu Y; Wang X; Xie R; Sun Y; Wang B; Cao H
    Front Immunol; 2022; 13():974305. PubMed ID: 36211363
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The human microbiome in disease and pathology.
    Manos J
    APMIS; 2022 Dec; 130(12):690-705. PubMed ID: 35393656
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TGR5 signaling mitigates parenteral nutrition-associated liver disease.
    Willis KA; Gomes CK; Rao P; Micic D; Moran ER; Stephenson E; Puchowicz M; Al Abdallah Q; Mims TS; Gosain A; Yin D; Talati AJ; Chang EB; Han JC; Pierre JF
    Am J Physiol Gastrointest Liver Physiol; 2020 Feb; 318(2):G322-G335. PubMed ID: 31905022
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Reciprocal Link between Oral, Gut Microbiota during Periodontitis: The Potential Role of Probiotics in Reducing Dysbiosis-Induced Inflammation.
    Di Stefano M; Santonocito S; Polizzi A; Mauceri R; Troiano G; Lo Giudice A; Romano A; Mascitti M; Isola G
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674600
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microbial dysbiosis is associated with human breast cancer.
    Xuan C; Shamonki JM; Chung A; Dinome ML; Chung M; Sieling PA; Lee DJ
    PLoS One; 2014; 9(1):e83744. PubMed ID: 24421902
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cancer-promoting effects of microbial dysbiosis.
    Sheflin AM; Whitney AK; Weir TL
    Curr Oncol Rep; 2014 Oct; 16(10):406. PubMed ID: 25123079
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exploring the human microbiome - A step forward for precision medicine in breast cancer.
    Jotshi A; Sukla KK; Haque MM; Bose C; Varma B; Koppiker CB; Joshi S; Mishra R
    Cancer Rep (Hoboken); 2023 Nov; 6(11):e1877. PubMed ID: 37539732
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Composition and Functional Potential of the Human Mammary Microbiota Prior to and Following Breast Tumor Diagnosis.
    Hoskinson C; Zheng K; Gabel J; Kump A; German R; Podicheti R; Marino N; Stiemsma LT
    mSystems; 2022 Jun; 7(3):e0148921. PubMed ID: 35642922
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Crosstalk between bile acid-activated receptors and microbiome in entero-hepatic inflammation.
    Thibaut MM; Bindels LB
    Trends Mol Med; 2022 Mar; 28(3):223-236. PubMed ID: 35074252
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Role of the Gut Microbiota in Bile Acid Metabolism.
    Ramírez-Pérez O; Cruz-Ramón V; Chinchilla-López P; Méndez-Sánchez N
    Ann Hepatol; 2017 Nov; 16(Suppl. 1: s3-105.):s15-s20. PubMed ID: 29080339
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.